Share
Explore BrainMass

Rofecobix (Vioxx) recall

As one of the most widely-used prescriptions withdrawn from the market, Rofecobix highlights issues facing public health leaders during a drug recall. With approval by the Food and Drug Administration in 1999, Merck marketed the drug for public use. In 2004, the drug was recalled for safety and cardiovascular problems developed in patients taking the medication (Topol, 2004). With nearly $2.5 billion dollars in sales and over 80 million people exposed to the drug, Merck's recall turned into a public firestorm of litigation cases against the corporation.

In this week's article by Topol, the author addresses the scandal surrounding safety concerns and the drug recall of Rofecobix. Use the Learning Resources as well as 2-4 additional resources from the Walden Library, current events, etc., to consider the facts in the case. Think about the traits and skills of the primary leaders. After considering the issues in the case, work with your group to address possible shortcomings of primary leadership and systemic issues. Also, as a group, think about strategies for improvements that use a systems thinking approach.

The Assignment-Part 1:

Individual Case Study Analysis (1-2 pages)
Create an individual case study analysis that includes:
A summary of the facts associated with the case including the primary leaders
A description of skills and traits of the primary leaders in this case

Solution Preview

The Assignment-Part 1:

Individual Case Study Analysis (1-2 pages)
Create an individual case study analysis that includes:
A summary of the facts associated with the case including the primary leaders

The facts associated with the case are that it represented the largest drug recall in United States history because the drug was prescribed to more than 20 million people as a pain reliever for arthritis across the globe. The case represented a gross violation of FDA oversight and also represented corporate illegality at its worst as many as 140,000 people were reported to have suffered from serious coronary heart disease from taking the drug, and this is just in the United States. Merck knew the dangers of their drug but chose to cover up these issues because the company, which was financially struggling, needed a new drug to ...

Solution Summary

Rofecobix (Vioxx) recall

$2.19